1. Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease

Mohammad A. Rafi , Paola Luzi, David A. Wenger*

Bioimpacts. 2020;10(2): 105-115. doi: 10.34172/bi.2020.13

PMCID: PMC7186542 PMID: 32363154 Scopus ID: 85090729388

Article

PDF

Full Text

XML

Cited By:

Krabbe disease (KD) is an autosomal recessive lysosomal disorder that imposes defective myelination in the peripheral and central nervous systems. Twitcher combining bone marrow transplantation with AAVrh10-mGALC can have a great extension of life in the murine model of KD.

Original Research

2. Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?

Mohammad A Rafi* , Paola Luzi, David A Wenger

BioImpacts. 2021;11(2): 135-146. doi: 10.34172/bi.2021.21

PMCID: PMC8022232 PMID: 33842284 Scopus ID: 85106877684

Article

PDF

Full Text

XML

Cited By:

Our results demonstrate that, it may be possible to treat human KD patients with high dose AAVrh10 without blood stem cell transplantation which would eliminate the side effects of HSCT.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons